Form D · Biotechnology
NOVADIGM THERAPEUTICS INC
Grand Forks, ND · CIK 0001439464
Offering snapshot reported Oct 3, 2013 · SEC filing
- Reported sold
- $7.01M Offering amount: $25M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 19, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 3, 2013 | Initial | $7,013,058 | No comparison | 5 | SEC filing |
| Feb 20, 2013 | Amendment | $20,588,274 | $10,002,358vs Oct 20, 2011 | 4 | SEC filing |
| Oct 20, 2011 | Amendment | $10,585,916 | $4,000,000vs Dec 16, 2009 | 4 | SEC filing |
| Dec 16, 2009 | Amendment | $6,585,916 | No comparison | 4 | SEC filing |
| Jul 3, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-203930
Source: Form D, filed Oct 3, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Todd Brady | Director |
| Boyd Clark | Director |
| Michael Timothy Cooke | Director, Executive |
| Gordon Douglas | Director |
| John Edwards, Jr. | Director |
| Fred Haney | Director, Executive |
| Tuomas Holmberg | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4201 James Ray Drive, Suite 2200 Reac 1 Buildings
Grand Forks, ND, 58202-6024
Grand Forks, ND, 58202-6024